JP2009278996A5 - - Google Patents

Download PDF

Info

Publication number
JP2009278996A5
JP2009278996A5 JP2009171169A JP2009171169A JP2009278996A5 JP 2009278996 A5 JP2009278996 A5 JP 2009278996A5 JP 2009171169 A JP2009171169 A JP 2009171169A JP 2009171169 A JP2009171169 A JP 2009171169A JP 2009278996 A5 JP2009278996 A5 JP 2009278996A5
Authority
JP
Japan
Prior art keywords
seq
polypeptide shown
polypeptide
cell
extracellular domain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009171169A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009278996A (ja
JP5258691B2 (ja
Filing date
Publication date
Priority claimed from PCT/US1999/031274 external-priority patent/WO2000053752A2/en
Priority claimed from PCT/US2000/004341 external-priority patent/WO2000053756A2/en
Priority claimed from PCT/US2000/005841 external-priority patent/WO2000053758A2/en
Priority claimed from PCT/US2000/007532 external-priority patent/WO2000070050A1/en
Priority claimed from PCT/US2000/015264 external-priority patent/WO2000073452A2/en
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/030873 external-priority patent/WO2001040465A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Application filed filed Critical
Publication of JP2009278996A publication Critical patent/JP2009278996A/ja
Publication of JP2009278996A5 publication Critical patent/JP2009278996A5/ja
Publication of JP5258691B2 publication Critical patent/JP5258691B2/ja
Application granted granted Critical
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009171169A 1999-12-23 2009-07-22 Ｉｌ−１７相同的ポリペプチドとその治療上の用途 Expired - Lifetime JP5258691B2 (ja)

Applications Claiming Priority (30)

Application Number Priority Date Filing Date Title
US17209699P 1999-12-23 1999-12-23
US60/172,096 1999-12-23
USPCT/US99/31274 1999-12-30
PCT/US1999/031274 WO2000053752A2 (en) 1999-03-08 1999-12-30 Promotion or inhibition of angiogenesis and cardiovascularization
US17548100P 2000-01-11 2000-01-11
US60/175,481 2000-01-11
PCT/US2000/004341 WO2000053756A2 (en) 1999-03-08 2000-02-18 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US00/04341 2000-02-18
USPCT/US00/05841 2000-03-02
PCT/US2000/005841 WO2000053758A2 (en) 1999-03-08 2000-03-02 Compositions and methods for the treatment of immune related diseases
US19100700P 2000-03-21 2000-03-21
US60/191,007 2000-03-21
PCT/US2000/007532 WO2000070050A1 (en) 1999-05-14 2000-03-21 Compositions and methods for the treatment of immune related diseases
USPCT/US00/07532 2000-03-21
PCT/US2000/015264 WO2000073452A2 (en) 1999-06-02 2000-06-02 Compositions and methods for the treatment of immune related diseases
USPCT/US00/15264 2000-06-02
US60/213,087 2000-06-20
US21380700P 2000-06-22 2000-06-22
US64484800A 2000-08-22 2000-08-22
US09/644,848 2000-08-22
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US00/23328 2000-08-24
US24283700P 2000-10-24 2000-10-24
US60/242,837 2000-10-24
PCT/US2000/030873 WO2001040465A2 (en) 1999-11-30 2000-11-10 Compositions and methods for the treatment of immune related diseases
USPCT/US00/30873 2000-11-10
US25364600P 2000-11-28 2000-11-28
US60/253,646 2000-11-28
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US00/32678 2000-12-01

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP2005143079A Division JP2005323597A (ja) 1999-12-23 2005-05-16 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Publications (3)

Publication Number Publication Date
JP2009278996A JP2009278996A (ja) 2009-12-03
JP2009278996A5 true JP2009278996A5 (enExample) 2011-08-18
JP5258691B2 JP5258691B2 (ja) 2013-08-07

Family

ID=40140243

Family Applications (10)

Application Number Title Priority Date Filing Date
JP2008109843A Expired - Fee Related JP5070117B2 (ja) 1999-12-23 2008-04-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009023863A Pending JP2009159968A (ja) 1999-12-23 2009-02-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009171169A Expired - Lifetime JP5258691B2 (ja) 1999-12-23 2009-07-22 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2010152694A Pending JP2010266454A (ja) 1999-12-23 2010-07-05 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2012012914A Pending JP2012115275A (ja) 1999-12-23 2012-01-25 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2012063772A Pending JP2012152218A (ja) 1999-12-23 2012-03-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2013038690A Withdrawn JP2013165712A (ja) 1999-12-23 2013-02-28 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014138440A Pending JP2014239685A (ja) 1999-12-23 2014-07-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014166220A Pending JP2015007091A (ja) 1999-12-23 2014-08-18 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014243369A Withdrawn JP2015077137A (ja) 1999-12-23 2014-12-01 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Family Applications Before (2)

Application Number Title Priority Date Filing Date
JP2008109843A Expired - Fee Related JP5070117B2 (ja) 1999-12-23 2008-04-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2009023863A Pending JP2009159968A (ja) 1999-12-23 2009-02-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Family Applications After (7)

Application Number Title Priority Date Filing Date
JP2010152694A Pending JP2010266454A (ja) 1999-12-23 2010-07-05 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2012012914A Pending JP2012115275A (ja) 1999-12-23 2012-01-25 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2012063772A Pending JP2012152218A (ja) 1999-12-23 2012-03-21 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2013038690A Withdrawn JP2013165712A (ja) 1999-12-23 2013-02-28 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014138440A Pending JP2014239685A (ja) 1999-12-23 2014-07-04 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014166220A Pending JP2015007091A (ja) 1999-12-23 2014-08-18 Ｉｌ−１７相同的ポリペプチドとその治療上の用途
JP2014243369A Withdrawn JP2015077137A (ja) 1999-12-23 2014-12-01 Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Country Status (10)

Country Link
EP (1) EP1240325B1 (enExample)
JP (10) JP5070117B2 (enExample)
AT (5) ATE519847T1 (enExample)
AU (1) AU2590901A (enExample)
CA (1) CA2391374A1 (enExample)
CY (1) CY1112334T1 (enExample)
DK (1) DK1240325T3 (enExample)
ES (7) ES2506665T3 (enExample)
PT (4) PT1897944E (enExample)
WO (1) WO2001046420A2 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6562578B1 (en) 1999-01-11 2003-05-13 Schering Corporation IL-17-like cytokine binding compounds and antibodies
JP3577586B2 (ja) 1998-05-15 2004-10-13 ジェネンテック・インコーポレーテッド Ｉｌ−１７相同的ポリペプチドとその治療用途
US7771719B1 (en) 2000-01-11 2010-08-10 Genentech, Inc. Pharmaceutical compositions, kits, and therapeutic uses of antagonist antibodies to IL-17E
EP1259253A2 (en) * 2000-02-29 2002-11-27 ZymoGenetics, Inc. Methods for promoting production of myelin by schwann cells
US7718397B2 (en) 2000-03-21 2010-05-18 Genentech, Inc. Nucleic acids encoding receptor for IL-17 homologous polypeptides and uses thereof
SI1274450T1 (sl) * 2000-04-18 2009-04-30 Schering Corp Medicinske uporabe agonistov in antagonistov IL-174
US20030092881A1 (en) * 2000-05-24 2003-05-15 Gorman Daniel M. Mammalian receptor proteins; related reagents and methods
US20030096969A1 (en) 2000-06-02 2003-05-22 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
WO2002008259A2 (en) * 2000-07-26 2002-01-31 Zymogenetics, Inc. Human cytokine receptor
EP1529843A3 (en) * 2000-08-11 2005-06-08 Eli Lilly & Company Novel secreted proteins and their uses
AU2001296229A1 (en) * 2000-10-13 2002-04-29 Eli Lilly And Company Methods of using a human il-17-related polypeptide to treat disease
US20040171109A1 (en) * 2000-11-10 2004-09-02 Dominik Haudenschild IL-17 receptor-like protein, uses thereof, and modulation of catabolic activity of il-17 cytokines on bone and cartilage
US20070160576A1 (en) 2001-06-05 2007-07-12 Genentech, Inc. IL-17A/F heterologous polypeptides and therapeutic uses thereof
AU2002351505B2 (en) * 2001-10-19 2008-04-03 Genentech, Inc. Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
EP1562587A4 (en) * 2002-09-11 2006-07-19 Genentech Inc COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASES OF THE IMMUNE SYSTEM
EP2314676A1 (en) * 2002-11-26 2011-04-27 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
WO2005051988A2 (en) * 2003-03-03 2005-06-09 Genentech, Inc. Compositions and methods for the treatment of systemic lupus erythematosis
EP2784084B2 (en) * 2003-07-08 2023-10-04 Novartis Pharma AG Antagonist antibodies to IL-17A/F heterologous polypeptides
ATE395083T1 (de) 2003-11-21 2008-05-15 Ucb Pharma Sa Verfahren zur behandlung von multipler sklerose durch hemmung der il-17-aktivität
US7501247B2 (en) 2004-05-03 2009-03-10 Schering Corporation Method of treating skin inflammation
US20050287593A1 (en) 2004-05-03 2005-12-29 Schering Corporation Use of cytokine expression to predict skin inflammation; methods of treatment
CN101001871A (zh) 2004-06-10 2007-07-18 津莫吉尼蒂克斯公司 可溶性ZcytoR14、抗ZcytoR14抗体和结合伴侣以及在炎症中的使用方法
JP2008513415A (ja) * 2004-09-21 2008-05-01 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 神経疾患の治療および予防のためのｉｌ−１７ｆの使用
US20070053872A1 (en) * 2005-08-04 2007-03-08 Moore Emma E Treatment of wounds using il-17b
US20070249533A1 (en) 2005-09-28 2007-10-25 Levin Steven D Il-17a and il-17f antagonists and methods of using the same
ATE467640T1 (de) 2006-02-10 2010-05-15 Zymogenetics Inc Lösliches il-17rcx4 und verfahren zu dessen anwendung bei entzündungen
AU2007310777A1 (en) 2006-10-26 2008-05-02 Novo Nordisk A/S IL-21 variants
CA2669109A1 (en) * 2006-11-08 2008-06-19 Zymogenetics, Inc. Il-17b for use in wound healing
CA2679588A1 (en) 2007-03-26 2008-10-02 Zymogenetics, Inc. Soluble il-17ra/rc fusion proteins and related methods
SG190626A1 (en) 2008-05-05 2013-06-28 Novimmune Sa Anti-il-17a/il-17f cross-reactive antibodies and methods of use thereof
US8790642B2 (en) 2008-08-29 2014-07-29 Genentech, Inc. Cross-reactive and bispecific anti-IL-17A/F antibodies
EP2406282A1 (en) 2009-03-11 2012-01-18 Novo Nordisk A/S Interleukin-21 variants having antagonistic binding to the il-21 receptor
SG174891A1 (en) 2009-04-01 2011-11-28 Genentech Inc Treatment of insulin-resistant disorders
GB0905972D0 (en) * 2009-04-06 2009-05-20 Medical Res Council Antibodies against IL-17BR
CN102458437B (zh) 2009-05-05 2015-06-10 诺维莫尼公司 抗il-17f抗体及其使用方法
WO2010142551A2 (en) * 2009-06-12 2010-12-16 Ablynx N.V. Single variable domain (vhh) antibodies to cytokines of the il-17 receptor family
JP2014506259A (ja) 2011-01-17 2014-03-13 ノヴォ ノルディスク アー／エス Ｉｌ−２１リガンド
UA117218C2 (uk) 2011-05-05 2018-07-10 Мерк Патент Гмбх Поліпептид, спрямований проти il-17a, il-17f та/або il17-a/f
AU2012324895B2 (en) 2011-10-19 2017-03-16 Galapagos Nv Antagonists of IL17C for the treatment of inflammatory disorders
JP6236948B2 (ja) * 2013-07-17 2017-11-29 東ソー株式会社 抗体精製用溶出液および当該溶出液を用いた抗体精製方法
KR20150050921A (ko) * 2013-11-01 2015-05-11 현대중공업 주식회사 폐열 회수용 연관식 보일러
EP3212665A2 (en) 2014-10-31 2017-09-06 F. Hoffmann-La Roche AG Anti-il-17a and il-17f cross reactive antibody variants and compositions comprising and methods of making and using same
CN107407677B (zh) 2015-01-28 2020-07-17 豪夫迈·罗氏有限公司 多发性硬化的基因表达标志和治疗

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073452A2 (en) * 1999-06-02 2000-12-07 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
MX9707021A (es) * 1995-03-23 1997-11-29 Immunex Corp Receptor de il-7.
WO2000070050A1 (en) * 1999-05-14 2000-11-23 Genentech, Inc. Compositions and methods for the treatment of immune related diseases
CA2288360A1 (en) * 1997-04-25 1998-11-05 Zymogenetics, Inc. Mammalian cytokine-like factor 7
EP1012260A4 (en) * 1997-07-16 2001-05-09 Human Genome Sciences Inc INTERLEUKINE-20
DE69841140D1 (de) * 1997-09-17 2009-10-22 Human Genome Sciences Inc Interleukin-17 rezeptor-ähnliches protein
US6482923B1 (en) * 1997-09-17 2002-11-19 Human Genome Sciences, Inc. Interleukin 17-like receptor protein
WO1999032632A1 (en) * 1997-12-19 1999-07-01 Millennium Pharmaceuticals, Inc. Novel embryo-derived interleukin related factor molecules and uses therefor
PT1490386E (pt) * 1998-03-10 2008-11-24 Genentech Inc Novos polipéptidos e ácidos nucleicos que os codificam
JP3577586B2 (ja) * 1998-05-15 2004-10-13 ジェネンテック・インコーポレーテッド Ｉｌ−１７相同的ポリペプチドとその治療用途
ATE444365T1 (de) * 1999-01-11 2009-10-15 Schering Corp Interleukin-17 verwandte zytokine aus säugetieren. dafür kodierende polynukleotide. verwendungen
AR022237A1 (es) * 1999-01-11 2002-09-04 Schering Corp Citoquinas mamiferas purificadas; reactivos y metodos relacionados
AU2596700A (en) * 1999-03-08 2000-09-28 Genentech Inc. Promotion or inhibition of angiogenesis and cardiovascularization
DK1190056T3 (da) * 1999-07-07 2007-07-30 Zymogenetics Inc Human cytokin receptor
JP2003527104A (ja) * 1999-12-23 2003-09-16 ジェネンテック・インコーポレーテッド Ｉｌ−１７相同的ポリペプチドとその治療上の用途

Similar Documents

Publication Publication Date Title
JP2009278996A5 (enExample)
Conroy et al. Antibody production, design and use for biosensor-based applications
HRP20201840T1 (hr) Postupci za ocjenjivanje imunološkog odgovora na terapijsko sredstvo
WO2010081114A3 (en) Oligonucleotide-coated affinity membranes and uses thereof
WO2010078950A3 (en) Antigens associated with endometriosis, psoriatic arthritis and psoriasis
MY162697A (en) Methods, devices and kits for detecting or monitoring acute kidney injury
DK1788391T3 (da) Biosensorindretning og fremgangsmåder til brug deraf
ATE476659T1 (de) Sensor für mehrere analyte
JP2011512817A5 (enExample)
WO2013065073A8 (en) Organic field -effect transistor sensor
BRPI0717633A2 (pt) Anticorpo, composição farmacêutica, e, métodos para detectar uma célula expressando cxcr7 em uma amostra biológica, para tratar, prevenir ou melhorar uma doença e para identificar um modulador de cxcr7
MX344935B (es) Analisis para detectar anticuerpos especificos a anticuerpos anti-ige terapeuticos y su uso en anafilaxis.
WO2010046443A3 (en) Methods for detection and diagnosis of a bone or cartilage disorder
WO2008054509A3 (en) Methods for assessing cell labeling
NZ593643A (en) Use of dr6 and p75 antagonists to promote survival of cells of the nervous system
JP2009524829A5 (enExample)
ATE466108T1 (de) Optoelektronisches detektionssystem
BR112014020513A2 (pt) Métodos e sistemas para amplificação de sinal de bioensaios
JP2011102805A5 (enExample)
JP2010528620A5 (enExample)
Wan et al. Invertase-mediated system for simple and rapid detection of pathogen
WO2007137679A3 (de) Vorrichtung und substanz zur isolierung von mesenchymalen stammzellen (msc)
JP2010006774A5 (enExample)
ATE499598T1 (de) Markierungsfreier einzelzelltest
BR112013005977A2 (pt) polipeptídeo isolado, anticorpo contra efrina-b2 e sua utilização, ácido nucleíco; vetor; célula; método de obtenção do polipeptídeo ou do anticorpo; método de detecção e/ou quantificação da efrina-b2; método de diagnóstico de uma enfermidade associada a expressão da efrina-b2; composição e sua utilização